Inflarx NV Schedule 13G passive stakes

Sirenia Capital Management LP and Alex Silverstein have jointly filed a Schedule 13G, reporting beneficial ownership of 6.1% of InflaRx N.V.'s ordinary shares.

Farallon Capital Management, L.L.C. and associated entities have reported beneficial ownership of 3,325,000 ordinary shares, representing 2.3% of the class, in InflaRx N.V.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 5.5% of Inflarx NV's common stock as of June 30, 2026.

Farallon Capital Management and its affiliated entities have reported beneficial ownership of over 5% of InflaRx N.V.'s ordinary shares.

TCG Crossover Fund III, L.P. and associated entities have reported a 9.8% beneficial ownership stake in InflaRx N.V. following a recent underwritten offering.

Suvretta Capital Management, LLC and Averill Master Fund, Ltd. have reported significant beneficial ownership in InflaRx N.V., with stakes of 11.7% and 11.4% respectively.